MARIA CHANDLER: Open Payments
NPI 1467918011 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 58 payments from 12 companies in 2025. Trend: 2023 $1,149 · 2024 $888 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $511 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $126 |
| Aimmune Therapeutics, Inc. | 4 | $84 |
| Ardelyx, Inc. | 3 | $72 |
| QOL Medical, LLC | 2 | $41 |
| Gilead Sciences, Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $19 |
Products named: SKYRIZI, ENTYVIO, XIFAXAN, RINVOQ, IBSRELA, ZENPEP, CREON, Sucraid.
Industry payments across OH — which companies pay providers there.
